Article Details
Retrieved on: 2018-01-26 03:07:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div><b>Bridgewater Associates</b> Ltd Partnership stated it has 0.08% of its portfolio in Celgene Corporation (NASDAQ:CELG). Among 33 analysts covering Celgene Corporation (NASDAQ:CELG), 18 have Buy rating, 2 Sell and 13 Hold. Therefore 55% are positive. Celgene Corporation had 127 analyst reports ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here